Nuwellis Inc NUWE

$0.34 +0.02 (6.83%)

Valuation

Market cap
1,175,000
Revenue TTM
$8,270,000
Net income TTM
$-17,520,000
PE ratio
0.00
Forward PE
—
Profit margin
-211.85%
Debt to equity
0.00

Trading

Volume
744,107
Avg volume
1,992,870
Day's range
$0.28 – $0.36
Shares out
3,647,000
Stochastic %K
1%
Beta
0.09
Analysts
Strong Buy
Price target
$11.00

Price

Company profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutio...

Show more

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Industry
Medical Devices
Sector
Healthcare
Phone
952 345 4200
Website
https://www.nuwellis.com
Address
12988 Valley View Road, Eden Prairie, United States

Latest news

Stocktwits

TwongStocks Oct 26, 8:57 PM
Tracking four NASDAQ stocks with reverse splits on Tuesday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am Tuesday morning. $ENLV 1 for 16. Will reduce outstanding shares from approx 24.51m to approx 1.53m. $NUWE 1 for 9. Will reduce outstanding shares from approx 5.0m to approx 555k. $PARA.X (formerly $BNZI) 1 for 10. Will reduce outstanding shares from approx 5.06m to approx 506k. $SCAG 1 for 15. Will reduce outstanding ADS from approx 72.61m to approx 4.84m.
0 replies
jerrik Oct 26, 6:22 PM
$NUWE Unfortunately, these biotechs are such easy targets for shorting even if they have strong drug candidates and good news. $CTXR is fighting to hard right now to come back up after repeated good news. Same with $HUMA and $GOVX is pretty much destroyed. ALthough in the case of $GOVX their management has been ridiculously silent so that is their own fault.
0 replies
Dominicstocks Oct 24, 4:50 PM
$NUWE Wow these scam artists have no soul . This is liquidity trap . To see how a toxic cycle completely erases an investor's shares, look at how rapidly Nuwellis has consolidated its stock just within the last few years: • June 2024: 1-for-20 reverse split • July 2025: 1-for-42 reverse split • June 2026: 1-for-35 reverse split • October 2026: A freshly announced 1-for-9 reverse split scheduled to take effect
0 replies
done84 Oct 24, 3:49 AM
$NUWE this shit was made to steal your money in 2012 as chfs. And they have been doing nothing else in the last 15 years. Real scam motherfuckers..down -99% in every year and 9 R/S. Should have been investigated and kicked out from the Nasdaq long time ago! Rot in hell chfs or nuwe wtf are you now you pos! 🖕🖕🖕
0 replies
thomasirons Oct 23, 8:20 PM
$NUWE NUWE's 9th REVERSE SPLIT INCOMING...DIVE FOR COVER!......
0 replies
thomasirons Oct 23, 8:17 PM
$NUWE A US General Shouted to "Commence ReShorting until $.0001".
0 replies
The_Gambl3r Oct 23, 8:11 PM
$NUWE 🤔
0 replies
stocklord2026 Oct 23, 7:28 PM
$NUWE banking huge here boys.
0 replies